Pharmaceutical Executive
WEBBy Miranda Schmalfuhs. September 9th 2024. In this part of their Pharmaceutical Executive video interview, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, and the potential health risks associated with them.
2022 Pharm Exec Top 50 Companies
WEBJun 9, 2022 · If 2020 was the “Year of COVID,” as we referred to it in our Pharm Exec 50 feature last year—reflecting on the pandemic’s scope and disruption on all facets of life—then 2021 was surely the year of COVID vaccines and treatments. And, through the prism of our latest rankings of the top 50 global biopharma players based on prescription …
Pharmaceutical Executive - PharmExec
WEBPharmaceutical Executive-02-01-2022. ... Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Pharm Exec's Top 50 Companies 2020
WEBJul 9, 2020 · Together, BMS and Celgene spent an estimated $9.4 billion in R&D last year, ranking second in this metric, with Johnson & Johnson and Merck manning third and fourth, respectively. Earlier this year, Brand Finance, the independent branded business valuation consultancy, named J&J its 2020 most valuable pharma company, due to J&J’s strong …
2021 Pharm Exec Top 50 Companies
WEBJun 9, 2021 · Manning the last two positions in the Pharma 50 top 10 are once again GlaxoSmithKline and Takeda. GSK, still planning to split the organization into two next year, recently announced plans to sell its complete stake in respiratory drug partner Innoviva (a royalty management company) for about $392 million.
Turning the Corner: A New Era of Pharma Sales Comes Into View
WEBNov 9, 2021 · It found that 43% of HCPs felt that in-person meetings helped build trust, connection, a point-of-contact relationship, and communication that was more personalized and engaging. In addition, they could get samples and have better access to supporting material. On the contrary, 40% of HCPs didn’t like the longer time commitment, physical …
Why Pharma Marketers Are Embracing Omnichannel Marketing
WEBJun 30, 2021 · Omnichannel marketing is emerging as the way forward by enhancing engagement across personal, non-personal, and media challenges to meet the integrated needs of providers, patients, and payers. Andrew Burkus. However, adopting an omnichannel approach is not a quick fix. It requires a fundamental shift in how marketers …
Podcasts - PharmExec
WEBPatients Outcomes Impact (POI™): The Evolution of Measuring Patient-Centered Investment. ZS Associates. January 17th 2024. Michael Shaw, JD, and Sharon Suchotliff, MPH, from ZS, discuss why measuring impact through a patient-centric lens is a business imperative for life sciences companies.
An Inside Look at Handling Alliance Management - PharmExec
WEBMar 10, 2022 · Astellas’ Mary Jo Struttmann, executive director of alliance management, has played an integral role in launching some of the company’s most successful partnerships, including the partnership with Seagen on bladder cancer drug PADCEV, as well as the Astellas/Pfizer partnership on XTANDI, a prostate cancer drug that has been …
Pharmaceutical Executive's 2021 Emerging Pharma Leaders
WEBMay 11, 2021 · Click on the links below to read the profiles of Pharm Exec's 2021 Emerging Pharma Leaders. Karen Akinsanya, Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D, Schrödinger. Sally Allain, Head of Johnson & Johnson Innovation, LLC – JLABS @ Washington, DC. Daniel Getts, CEO, Myeloid Therapeutics.